Curcumin derivatives have also been shown to decrease HER2+ breast cancer cell proliferation, overcome therapeutic resistance (Lien et al., 2015), and hamper migration (Novitasari et al., 2021). The gene discussed is ERBB2; the disease is breast carcinoma.